Pépin S - Search Results

1

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.

Pépin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M. Pépin S, et al. Vaccine. 2013 Nov 12;31(47):5572-8. doi: 10.1016/j.vaccine.2013.08.069. Epub 2013 Sep 7. Vaccine. 2013. PMID: 24016810 Clinical Trial.

2

Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip.

Delore V, Salamand C, Marsh G, Arnoux S, Pepin S, Saliou P. Delore V, et al. Among authors: pepin s. Vaccine. 2006 Mar 6;24(10):1586-92. doi: 10.1016/j.vaccine.2005.10.008. Epub 2005 Oct 18. Vaccine. 2006. PMID: 16271424

3

Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children.

Chotpitayasunondh T, Thisyakorn U, Pancharoen C, Pepin S, Nougarede N. Chotpitayasunondh T, et al. Among authors: pepin s. PLoS One. 2008;3(12):e4028. doi: 10.1371/journal.pone.0004028. Epub 2008 Dec 29. PLoS One. 2008. PMID: 19112513 Free PMC article. Clinical Trial.

4

Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.

Höschler K, Gopal R, Andrews N, Saville M, Pepin S, Wood J, Zambon MC. Höschler K, et al. Among authors: pepin s. Influenza Other Respir Viruses. 2007 Sep-Nov;1(5-6):199-206. doi: 10.1111/j.1750-2659.2007.00033.x. Influenza Other Respir Viruses. 2007. PMID: 19453427 Free PMC article. Clinical Trial.

5

Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults.

Leroux-Roels I, Van der Wielen M, Kafeja F, Vandermeulen C, Lazarus R, Snape MD, John T, Carre C, Nougarede N, Pepin S, Leroux-Roels G, Hoppenbrouwers K, Pollard AJ, Van Damme P. Leroux-Roels I, et al. Among authors: pepin s. Vaccine. 2009 Nov 16;27(49):6918-25. doi: 10.1016/j.vaccine.2009.08.110. Epub 2009 Sep 15. Vaccine. 2009. PMID: 19761837 Clinical Trial.

6

Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin.

Garcia JM, Pepin S, Lagarde N, Ma ES, Vogel FR, Chan KH, Chiu SS, Peiris JS. Garcia JM, et al. Among authors: pepin s. PLoS One. 2009 Nov 20;4(11):e7918. doi: 10.1371/journal.pone.0007918. PLoS One. 2009. PMID: 19936250 Free PMC article.

7

Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.

Van der Vliet D, Pepin S, Lambert M, Fauchoux N, Donazzolo Y, Dupuy M, Dakowski C, Denis M. Van der Vliet D, et al. Among authors: pepin s. Hum Vaccin. 2010 Oct;6(10):823-8. doi: 10.4161/hv.6.10.13600. Epub 2010 Oct 1. Hum Vaccin. 2010. PMID: 20935517 Clinical Trial.

8

Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.

Cadorna-Carlos JB, Nolan T, Borja-Tabora CF, Santos J, Montalban MC, de Looze FJ, Eizenberg P, Hall S, Dupuy M, Hutagalung Y, Pépin S, Saville M. Cadorna-Carlos JB, et al. Among authors: pepin s. Vaccine. 2015 May 15;33(21):2485-92. doi: 10.1016/j.vaccine.2015.03.065. Epub 2015 Apr 2. Vaccine. 2015. PMID: 25843270 Clinical Trial.

9

Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study.

Pepin S, Szymanski H, Rochín Kobashi IA, Villagomez Martinez S, González Zamora JF, Brzostek J, Huang LM, Chiu CH, Chen PY, Ahonen A, Forstén A, Seppä I, Quiroz RF, Korhonen T, Rivas E, Monfredo C, Hutagalung Y, Menezes J, Vesikari T. Pepin S, et al. Hum Vaccin Immunother. 2016 Dec;12(12):3072-3078. doi: 10.1080/21645515.2016.1212143. Epub 2016 Aug 26. Hum Vaccin Immunother. 2016. PMID: 27565435 Free PMC article. Clinical Trial.

10

Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.

Lazarus R, Kelly S, Snape MD, Vandermeulen C, Voysey M, Hoppenbrouwers K, Hens A, Van Damme P, Pepin S, Leroux-Roels I, Leroux-Roels G, Pollard AJ. Lazarus R, et al. Among authors: pepin s. PLoS One. 2016 Nov 4;11(11):e0165384. doi: 10.1371/journal.pone.0165384. eCollection 2016. PLoS One. 2016. PMID: 27814377 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results